The small leucine-rich proteoglycan decorin has been demonstrated to be a key regulator of collagen fibrillogenesis; decorin deficiencies lead to irregularly shaped collagen fibrils and weakened material behavior in postnatal murine connective tissues. In an in vitro investigation of the contributions of decorin to tissue organization and material behavior, model tissues were engineered by seeding embryonic fibroblasts, harvested from 12.5-13.5 days gestational aged decorin null (Dcn ؊/؊ ) or wild-type mice, within type I collagen gels. The resulting three-dimensional collagen matrices were cultured for 4 weeks under static tension. The collagen matrices seeded with Dcn ؊/؊ cells exhibited greater contraction, cell density, ultimate tensile strength, and elastic modulus than those seeded with wild-type cells. Ultrastructurally, the matrices seeded with Dcn ؊/؊ cells contained a greater density of collagen. The decorin-null tissues contained more biglycan than control tissues, suggesting that this related proteoglycan compensated for the absence of decorin. The effect of transforming growth factor- (TGF-), which is normally sequestered by decorin, was also investigated in this study. The addition of TGF-1 to the matrices seeded with wild-type cells improved their contraction and mechanical strength, whereas blocking TGF-1 in the Dcn ؊/؊ cell-seeded matrices significantly reduced the collagen gel contraction. These results indicate that the inhibitory interaction between decorin and TGF-1 significantly influenced the matrix organization and material behavior of these in vitro model tissues.Decorin, a member of the small leucine-rich proteoglycan family (1), regulates a myriad of functions in the extracellular matrix including collagen fibrillogenesis (2), collagen degradation (3), cell growth (4 -6), and extracellular signaling (7,8). Decorin consists of a core protein of ϳ40 kDa attached to a single chondroitin/dermatan sulfate glycosaminoglycan (GAG) 2 chain (9, 10). Decorin's regulation of collagen fibrillogenesis is putatively facilitated through binding of type I collagen molecules to the inner leucine-rich region of decorin core proteins (11). Decorin also binds to other collagens including types II, III, VI, and XIV, thereby affecting a variety of extracellular matrix components (12).Decorin also participates in many important intracellular and extracellular signaling processes, including ligation of the epidermal growth factor receptor (5,7,13,14), which up-regulates cyclin-dependent kinase inhibitor p21 and ultimately arrests cells in the G 1 phase of the cell cycle. In addition, decorin has been shown to bind and inhibit all three mammalian isoforms of transforming growth factor- (TGF-1, -2, -3) (12, 15, 16), even when bound to collagen. As with collagen, this binding takes place via the protein core and not the GAG chains (5, 17). Conversely, the degradation of decorin by matrix metalloproteases, such as during tissue repair processes, releases the bound TGF- (18, 19). Thus, whether binding ...